Developer docs
API playgroundTry for free, no card

Search company profiles

SCHOTT MINIFAB

Full company profile

uuid000ere5

Namestring
SCHOTT MINIFAB
Legal namestring
SCHOTT MINIFAB
Company typeenum
Private
Founded yearint
2003
Descriptiontext

SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) and a business unit of SCHOTT AG, specializing in microfluidic devices, microarrays, and consumables for the in vitro diagnostics (IVD) and life science research markets. The company serves IVD manufacturers developing tools for infectious disease detection, point-of-care diagnostics, molecular diagnostics, immunological diagnostics, and lab-on-a-chip applications, as well as life science research institutions working on next-generation research tools including NGS, protein, and DNA microarrays. It is based in Melbourne, Australia with production facilities in Phoenix (USA), Jena (Germany), and Melbourne, and operates with 101-250 employees.

The company's product platform rests on three proprietary technology brands. SCHOTT® Microarrays is a microarray printing platform pioneered over two decades ago in response to the Human Genome Project and refined continuously since. NEXTERION® is the registered glass substrate family, offered in coated variants for DNA and protein microarrays, bonded variants for microfluidic and NGS applications, and structured variants for customized biochip sizes. SCHOTT® Reagent Blister is a high gas-barrier, chemically compatible reagent storage technology that integrates dry/wet assay reagents directly onto consumables.

SCHOTT MINIFAB makes money through two primary service streams: contract product development (a Stage Gate Process from concept to commercialization covering R&D support, prototype feasibility, and manufacturing infrastructure development) and contract manufacturing (pilot lines through fully automated high-volume production), complemented by pilot line services, precision injection molding, and microfluidics solutions. Pricing is quote-based and not publicly disclosed, with all customer relationships established through direct B2B enterprise engagement via a quote request form on the company website. In September 2021, SCHOTT AG acquired Applied Microarrays Inc. (AMI) in Arizona to expand US bioscience capacity, and SCHOTT MINIFAB is wholly owned through SCHOTT AG, which is itself owned by the Carl Zeiss Foundation.

Short descriptiontext

SCHOTT MINIFAB is a SCHOTT AG business unit that designs, develops, and manufactures microfluidic devices, microarrays, and diagnostic consumables as a CDMO for IVD manufacturers and life science research institutions, operating production facilities in the USA, Germany, and Australia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microfluidic device manufacturing, diagnostic consumables production, microarray printing services, glass substrate fabrication, contract development manufacturing
Industry2 codes
1Sterile Fill-Finish & Aseptic Manufacturing CDMO
CodeHLAGABAHPrimaryYes
2GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
CodeHLAGAHALPrimaryNo
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Plastics Products, Nec3089
Product category
Diagnostic and Life Science Consumables Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Contract Product Development
TypeProfessional Services
Description

Stage-gate development services supporting customers from concept through commercialization, including R&D phase support, prototype development for feasibility studies, and scalable manufacturing infrastructure development.

schott.com
2Contract Manufacturing
TypeProfessional Services
Description

Manufacturing services ranging from low-volume pilot lines using purpose-built infrastructure to fully automated high-volume production for diagnostic and life science research consumables.

schott.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1SCHOTT® Microarrays
Description

Pioneered over two decades ago in response to the Human Genome Project, SCHOTT® Microarrays have been refined into a comprehensive microarray printing platform for biosensor and diagnostic applications.

schott.com
+2 more records
Core offering1 text field

SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) that produces microfluidic devices and consumables for in vitro diagnostics and life science research. It manufactures physical products including SCHOTT® Microarrays, NEXTERION® glass substrates, and SCHOTT® Reagent Blisters, and provides contract product development, contract manufacturing, pilot line, precision injection molding, and microfluidics services from facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Seamless transition from concept to commercialization through Stage Gate Process
Product overview1 text field

SCHOTT MINIFAB is a contract design, development, and manufacturing company specializing in in vitro diagnostics and life science research consumables. The company operates a platform of physical products including SCHOTT® Microarrays (pioneered over 20 years ago for the Human Genome Project), NEXTERION® glass substrates (available in bonded, coated, and structured variants for biochip, microfluidic, and lab-on-chip applications), and SCHOTT® Reagent Blister technology for reagent containment. These products are complemented by comprehensive services including contract product development (Concept to Commercialization stage gate process), contract manufacturing (from pilot lines to high-volume automated production), pilot line services, precision injection molding, and microfluidics solutions. The company maintains production facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).

Product and service8 records
1SCHOTT® Microarrays
CategoryMicroarray Products
Description

A microarray printing platform offering comprehensive DNA and protein microarray solutions for diagnostics and life science applications; targeted at IVD manufacturers and life science research organizations.

2NEXTERION® Glass Substrates
CategoryGlass Substrates
Description

Glass substrate product line (bonded, coated, and structured variants) for biochip, microfluidic, lab-on-chip, molecular diagnostics, immunological diagnostics, and life science research applications; targeted at diagnostics manufacturers and research tool developers.

3SCHOTT® Reagent Blister
CategoryReagent Containment Products
Description

Blister-based reagent storage technology that integrates assay reagents onto IVD and life science consumables using high gas barrier, chemically and biologically compatible materials; targeted at IVD manufacturers and diagnostics developers.

4Contract Product Development
CategoryContract Development Services
Description

Stage gate (Concept to Commercialization) development services spanning R&D support, prototype feasibility studies, and scalable manufacturing infrastructure development for diagnostic and life science consumables; targeted at product developers and IVD manufacturers.

5Contract Manufacturing
CategoryContract Manufacturing Services
Description

Manufacturing services ranging from low-volume pilot line production to fully automated high-volume production for diagnostic and life science research consumables; targeted at IVD manufacturers and life science research organizations.

6Pilot Line Services
CategoryContract Manufacturing Services
Description

Pilot line services supporting small-scale production and process validation for diagnostic and life science consumables prior to full-scale manufacturing; targeted at IVD product developers.

7Precision Injection Molding Solutions
CategoryManufacturing Services
Description

Precision injection molding services for high-volume manufacturing of diagnostic and life science consumables; targeted at IVD manufacturers and life science research consumables producers.

8Microfluidics Solutions
CategoryManufacturing Services
Description

Microfluidics design, development, and manufacturing solutions including lab-on-a-chip technology for diagnostic and life science applications; targeted at IVD manufacturers and point-of-care diagnostics developers.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-09-28
Description

SCHOTT signed an agreement to acquire Applied Microarrays Inc. (AMI), a microarray solutions company based in Arizona, to expand bioscience capabilities and manufacturing presence in the United States. The acquisition enhances SCHOTT's microarray printing and biosensor capabilities, especially for point-of-care diagnostics such as infectious disease detection.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bio-Rad manufactures life science research and clinical diagnostics consumables, including digital PCR, qPCR, microarray, and flow cytometry products. Directly comparable to SCHOTT MINIFAB as a developer and manufacturer of IVD and life science research consumables serving overlapping customer segments.

TypeDirect peer
Description

Standard BioTools designs and manufactures microfluidic-based consumables and instruments for proteomics, genomics, and single-cell analysis. Highly comparable to SCHOTT MINIFAB's microarray/microfluidic consumables business with similar customer base in life science research.

TypeDirect peer
Description

Bio-Techne develops and manufactures reagents, assay kits, and proprietary platforms for life science research and diagnostics. Comparable to SCHOTT MINIFAB in serving IVD and life sciences with specialized consumables, microarrays, and contract capabilities.

TypeBroad incumbent
Description

Agilent is a broad analytical instruments and life sciences consumables provider with microarray, genomics, and diagnostics offerings. Comparable to SCHOTT MINIFAB as a larger incumbent with microarray and life science tools capabilities, though much broader in scope.

TypeBroad incumbent
Description

Thermo Fisher is the largest life sciences tools and services provider with a comprehensive microarray, IVD, and CDMO portfolio. Comparable to SCHOTT MINIFAB as a dominant incumbent offering microarray/IVD consumables and contract manufacturing at much greater scale.

TypeBroad incumbent
Description

Danaher owns multiple diagnostics and life sciences businesses (Beckman Coulter, Cepheid, Leica, Cytiva). Comparable to SCHOTT MINIFAB as a diversified diagnostics and life sciences consumables parent with significant CDMO exposure via Cytiva.

TypeEmerging player
Description

10x Genomics develops single-cell and spatial genomics consumables and instruments using proprietary microfluidic barcode technology. Comparable to SCHOTT MINIFAB's microfluidic consumables capabilities, though specialized to single-cell and spatial genomics workflows.

TypeBroad incumbent
Description

Sartorius provides bioprocessing and lab consumables, including CDMO and contract manufacturing services for life sciences. Comparable to SCHOTT MINIFAB as a broader life science tools/CDMO player serving IVD and life sciences customers.

TypeDirect peer
Description

STRATEC is a leading contract development and manufacturing partner for IVD and life science instrumentation and consumables. Direct CDMO peer to SCHOTT MINIFAB serving in vitro diagnostics manufacturers with development and manufacturing services.

TypeBroad incumbent
Description

PerkinElmer (now split into Revvity and the applied sciences business) provides life sciences, diagnostics, and analytical instruments including microarray and microfluidic products. Comparable to SCHOTT MINIFAB as an incumbent with overlapping microarray and diagnostics consumables capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SCHOTT MINIFAB

Diagnostic and Life Science Consumables Manufacturingschott-minifab.com

SCHOTT MINIFAB is a SCHOTT AG business unit that designs, develops, and manufactures microfluidic devices, microarrays, and diagnostic consumables as a CDMO for IVD manufacturers and life science research institutions, operating production facilities in the USA, Germany, and Australia.

What SCHOTT MINIFAB does

SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) and a business unit of SCHOTT AG, specializing in microfluidic devices, microarrays, and consumables for the in vitro diagnostics (IVD) and life science research markets. The company serves IVD manufacturers developing tools for infectious disease detection, point-of-care diagnostics, molecular diagnostics, immunological diagnostics, and lab-on-a-chip applications, as well as life science research institutions working on next-generation research tools including NGS, protein, and DNA microarrays. It is based in Melbourne, Australia with production facilities in Phoenix (USA), Jena (Germany), and Melbourne, and operates with 101-250 employees.

The company's product platform rests on three proprietary technology brands. SCHOTT® Microarrays is a microarray printing platform pioneered over two decades ago in response to the Human Genome Project and refined continuously since. NEXTERION® is the registered glass substrate family, offered in coated variants for DNA and protein microarrays, bonded variants for microfluidic and NGS applications, and structured variants for customized biochip sizes. SCHOTT® Reagent Blister is a high gas-barrier, chemically compatible reagent storage technology that integrates dry/wet assay reagents directly onto consumables.

SCHOTT MINIFAB makes money through two primary service streams: contract product development (a Stage Gate Process from concept to commercialization covering R&D support, prototype feasibility, and manufacturing infrastructure development) and contract manufacturing (pilot lines through fully automated high-volume production), complemented by pilot line services, precision injection molding, and microfluidics solutions. Pricing is quote-based and not publicly disclosed, with all customer relationships established through direct B2B enterprise engagement via a quote request form on the company website. In September 2021, SCHOTT AG acquired Applied Microarrays Inc. (AMI) in Arizona to expand US bioscience capacity, and SCHOTT MINIFAB is wholly owned through SCHOTT AG, which is itself owned by the Carl Zeiss Foundation.

SCHOTT MINIFAB firmographics

Firmographics
Name
SCHOTT MINIFAB
Legal name
SCHOTT MINIFAB
Website
https://schott-minifab.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
101–250 employees
Short description
SCHOTT MINIFAB is a SCHOTT AG business unit that designs, develops, and manufactures microfluidic devices, microarrays, and diagnostic consumables as a CDMO for IVD manufacturers and life science research institutions, operating production facilities in the USA, Germany, and Australia.
Ownership category
akta.pro rank

SCHOTT MINIFAB industry classification

Industry
Product category
Diagnostic and Life Science Consumables Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Plastics Products, Nec (3089)
akta.pro primary industry
Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
akta.pro secondary industry
GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

Keywords

  • Microfluidic device manufacturing
  • Diagnostic consumables production
  • Microarray printing services
  • Glass substrate fabrication
  • Contract development manufacturing

Where SCHOTT MINIFAB is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices3 records

Markets served

SCHOTT MINIFAB business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Contract Product Development: Stage-gate development services supporting customers from concept through commercialization, including R&D phase support, prototype development for feasibility studies, and scalable manufacturing infrastructure development.
  2. Contract Manufacturing: Manufacturing services ranging from low-volume pilot lines using purpose-built infrastructure to fully automated high-volume production for diagnostic and life science research consumables.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

SCHOTT MINIFAB product offering

Product offering

Core offering

SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) that produces microfluidic devices and consumables for in vitro diagnostics and life science research. It manufactures physical products including SCHOTT® Microarrays, NEXTERION® glass substrates, and SCHOTT® Reagent Blisters, and provides contract product development, contract manufacturing, pilot line, precision injection molding, and microfluidics services from facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).

Product overview

SCHOTT MINIFAB is a contract design, development, and manufacturing company specializing in in vitro diagnostics and life science research consumables. The company operates a platform of physical products including SCHOTT® Microarrays (pioneered over 20 years ago for the Human Genome Project), NEXTERION® glass substrates (available in bonded, coated, and structured variants for biochip, microfluidic, and lab-on-chip applications), and SCHOTT® Reagent Blister technology for reagent containment. These products are complemented by comprehensive services including contract product development (Concept to Commercialization stage gate process), contract manufacturing (from pilot lines to high-volume automated production), pilot line services, precision injection molding, and microfluidics solutions. The company maintains production facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).

Differentiator

Problem solved

Functional benefit

Brands

  • SCHOTT® Microarrays: Pioneered over two decades ago in response to the Human Genome Project, SCHOTT® Microarrays have been refined into a comprehensive microarray printing platform for biosensor and diagnostic applications.
  • NEXTERION®
  • SCHOTT® Reagent Blister

Products and services

  • SCHOTT® Microarrays A microarray printing platform offering comprehensive DNA and protein microarray solutions for diagnostics and life science applications; targeted at IVD manufacturers and life science research organizations.
  • NEXTERION® Glass Substrates Glass substrate product line (bonded, coated, and structured variants) for biochip, microfluidic, lab-on-chip, molecular diagnostics, immunological diagnostics, and life science research applications; targeted at diagnostics manufacturers and research tool developers.
  • SCHOTT® Reagent Blister Blister-based reagent storage technology that integrates assay reagents onto IVD and life science consumables using high gas barrier, chemically and biologically compatible materials; targeted at IVD manufacturers and diagnostics developers.
  • Contract Product Development Stage gate (Concept to Commercialization) development services spanning R&D support, prototype feasibility studies, and scalable manufacturing infrastructure development for diagnostic and life science consumables; targeted at product developers and IVD manufacturers.
  • Contract Manufacturing Manufacturing services ranging from low-volume pilot line production to fully automated high-volume production for diagnostic and life science research consumables; targeted at IVD manufacturers and life science research organizations.
  • Pilot Line Services Pilot line services supporting small-scale production and process validation for diagnostic and life science consumables prior to full-scale manufacturing; targeted at IVD product developers.
  • Precision Injection Molding Solutions Precision injection molding services for high-volume manufacturing of diagnostic and life science consumables; targeted at IVD manufacturers and life science research consumables producers.
  • Microfluidics Solutions Microfluidics design, development, and manufacturing solutions including lab-on-a-chip technology for diagnostic and life science applications; targeted at IVD manufacturers and point-of-care diagnostics developers.

Quantifiable outcome

  • Seamless transition from concept to commercialization through Stage Gate Process

Companies that use SCHOTT MINIFAB

Customer profile

Segments2 records

Ideal customer profiles2 records

SCHOTT MINIFAB technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

SCHOTT MINIFAB partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Applied Microarrays Inc. (AMI)coreStrategic or Co-development Partner · 28 September 2021SCHOTT signed an agreement to acquire Applied Microarrays Inc. (AMI), a microarray solutions company based in Arizona, to expand bioscience capabilities and manufacturing presence in the United States. The acquisition enhances SCHOTT's microarray printing and biosensor capabilities, especially for point-of-care diagnostics such as infectious disease detection.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

SCHOTT MINIFAB competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Bio-Rad manufactures life science research and clinical diagnostics consumables, including digital PCR, qPCR, microarray, and flow cytometry products. Directly comparable to SCHOTT MINIFAB as a developer and manufacturer of IVD and life science research consumables serving overlapping customer segments.
  • Standard BioTools (formerly Fluidigm): Standard BioTools designs and manufactures microfluidic-based consumables and instruments for proteomics, genomics, and single-cell analysis. Highly comparable to SCHOTT MINIFAB's microarray/microfluidic consumables business with similar customer base in life science research.
  • Bio-Techne: Bio-Techne develops and manufactures reagents, assay kits, and proprietary platforms for life science research and diagnostics. Comparable to SCHOTT MINIFAB in serving IVD and life sciences with specialized consumables, microarrays, and contract capabilities.
  • STRATEC Biomedical: STRATEC is a leading contract development and manufacturing partner for IVD and life science instrumentation and consumables. Direct CDMO peer to SCHOTT MINIFAB serving in vitro diagnostics manufacturers with development and manufacturing services.

Broad incumbents

  • Agilent Technologies: Agilent is a broad analytical instruments and life sciences consumables provider with microarray, genomics, and diagnostics offerings. Comparable to SCHOTT MINIFAB as a larger incumbent with microarray and life science tools capabilities, though much broader in scope.
  • Thermo Fisher Scientific: Thermo Fisher is the largest life sciences tools and services provider with a comprehensive microarray, IVD, and CDMO portfolio. Comparable to SCHOTT MINIFAB as a dominant incumbent offering microarray/IVD consumables and contract manufacturing at much greater scale.
  • Danaher: Danaher owns multiple diagnostics and life sciences businesses (Beckman Coulter, Cepheid, Leica, Cytiva). Comparable to SCHOTT MINIFAB as a diversified diagnostics and life sciences consumables parent with significant CDMO exposure via Cytiva.
  • Sartorius AG: Sartorius provides bioprocessing and lab consumables, including CDMO and contract manufacturing services for life sciences. Comparable to SCHOTT MINIFAB as a broader life science tools/CDMO player serving IVD and life sciences customers.
  • PerkinElmer: PerkinElmer (now split into Revvity and the applied sciences business) provides life sciences, diagnostics, and analytical instruments including microarray and microfluidic products. Comparable to SCHOTT MINIFAB as an incumbent with overlapping microarray and diagnostics consumables capabilities.

Emerging players

  • 10x Genomics: 10x Genomics develops single-cell and spatial genomics consumables and instruments using proprietary microfluidic barcode technology. Comparable to SCHOTT MINIFAB's microfluidic consumables capabilities, though specialized to single-cell and spatial genomics workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

SCHOTT MINIFAB social profiles

Digital presence

SCHOTT MINIFAB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SCHOTT MINIFAB leadership team

Management profile

Number of profiles

Profiles1 record

SCHOTT MINIFAB subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

SCHOTT MINIFAB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SCHOTT MINIFAB M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SCHOTT MINIFAB

What does SCHOTT MINIFAB do?

SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) that produces microfluidic devices and consumables for in vitro diagnostics and life science research. It manufactures physical products including SCHOTT® Microarrays, NEXTERION® glass substrates, and SCHOTT® Reagent Blisters, and provides contract product development, contract manufacturing, pilot line, precision injection molding, and microfluidics services from facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).

Is SCHOTT MINIFAB a public or private company?

SCHOTT MINIFAB is a private company. It is classified as corporate owned and is currently operating.

When was SCHOTT MINIFAB founded?

SCHOTT MINIFAB was founded in 2003. It employs 101 to 250 people.

Where is SCHOTT MINIFAB based?

SCHOTT MINIFAB is headquartered in Melbourne, Australia, in the Oceania region.

How does SCHOTT MINIFAB make money?

Two revenue lines are on record. Contract Product Development is the primary driver. The others are contract Manufacturing.

Who are SCHOTT MINIFAB's main competitors?

Direct peers on record are Bio-Rad Laboratories, Standard BioTools (formerly Fluidigm), Bio-Techne and STRATEC Biomedical. Broad incumbents are Agilent Technologies, Thermo Fisher Scientific, Danaher, Sartorius AG and PerkinElmer. 10x Genomics is listed as an emerging player.

Does SCHOTT MINIFAB have an API?

No public API is recorded for SCHOTT MINIFAB.

What industry is SCHOTT MINIFAB in?

SCHOTT MINIFAB's product category is Diagnostic and Life Science Consumables Manufacturing. Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 3391 and its SIC code is 3089.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals